Showing results (151-160 of 165) with videos related to
Sort By:
Pageof 17
The Pharmacogenomics Journal|June 6, 2007
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapyA Ruzzo, F Graziano, F Loupakis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)S Cascinu, F Graziano, F Ferraù, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2018
Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONOC Cremolini, C Antoniotti, S Lonardi, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|December 22, 2009
A survey on Prader-Willi syndrome in the Italian population: prevalence of historical and clinical signsA Crinò, G Di Giorgio, C Livieri, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2018
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONOE Dell'Aquila, C Cremolini, T Zeppola, et al.ESMO Open|August 21, 2025
Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled studyA R Filippi, M R García Campelo, J-B Paoli, et al.Oncogene|August 28, 2024
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical modelsF Pantano, S Simonetti, M Iuliani, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2014
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trialF Ciardiello, N Normanno, E Maiello, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2016
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOXF Ciardiello, N Normanno, E Martinelli, et al.Journal of Bone Oncology|July 26, 2018
Bone metastases in biliary cancers: A multicenter retrospective surveyD Santini, G Brandi, G Aprile, et al.Pageof 17